The IMS Health Holdings (NYSE:IMS) IPO represents the second-biggest IPO so far this year in the U.S.
IMS Heath’s IMS One portfolio of products includes 360 Vantage|IMS Health (Chandler, AZ). 360 Vantage was acquired by IMS Heath in May of 2013.
The IMS Health Holdings (NYSE:IMS) IPO represents the second-biggest IPO so far this year in the U.S.
IMS Heath’s IMS One portfolio of products includes 360 Vantage|IMS Health (Chandler, AZ). 360 Vantage was acquired by IMS Heath in May of 2013.
Ventana signs companion diagnostic agreement with international biotech for antibody drug conjugate programContinue reading
Mayor Stanton and the Phoenix City Council Take Next Steps to Advance ‘Arizona Biomedical Corridor’
An international research group, led by Arizona State University professor Qiang “Shawn” Chen, has developed a new generation of potentially safer and more cost-effective therapeutics against West Nile virus and other pathogens.Continue reading
25% of all the stem cell units released for use by CBR have been collected under their free access initiativeContinue reading
Dr. Daniel D. Von Hoff, who has been instrumental in developing numerous new cancer treatments, is among this year’s recipients of the Award of Excellence from the Hope Funds for Cancer Research.Continue reading